(Q40469654)

English

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

type 2 diabetes

0 references

Giuseppe Remuzzi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

B Schievink

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

T Kröpelin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

S Mulder

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H-H Parving

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

J Dwyer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

P Vemer

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

H J Lambers Heerspink

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

27 November 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

64-71

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

How does early chronic kidney disease progress? A background paper prepared for the UK Consensus Conference on early chronic kidney disease

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Type 2 diabetes in youth: epidemiology and pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

The lifetime cost of diabetes and its implications for diabetes prevention

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Combined angiotensin inhibition for the treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Chronic kidney disease and the risk of end-stage renal disease versus death

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

The global spread of type 2 diabetes mellitus in children and adolescents.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12583

21 January 2018

Identifiers

10.1111/DOM.12583

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26434564%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40469654&oldid=1494063785"